Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee.


Journal

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
ISSN: 1523-6536
Titre abrégé: Biol Blood Marrow Transplant
Pays: United States
ID NLM: 9600628

Informations de publication

Date de publication:
12 2020
Historique:
received: 28 05 2020
revised: 19 07 2020
accepted: 19 07 2020
pubmed: 28 7 2020
medline: 15 12 2020
entrez: 28 7 2020
Statut: ppublish

Résumé

The current COVID-19 pandemic, caused by SARS-CoV-2, has impacted many facets of hematopoietic cell transplantation (HCT) in both developed and developing countries. Realizing the challenges as a result of this pandemic affecting the daily practice of the HCT centers and the recognition of the variability in practice worldwide, the Worldwide Network for Blood and Marrow Transplantation (WBMT) and the Center for International Blood and Marrow Transplant Research's (CIBMTR) Health Services and International Studies Committee have jointly produced an expert opinion statement as a general guide to deal with certain aspects of HCT, including diagnostics for SARS-CoV-2 in HCT recipient, pre- and post-HCT management, donor issues, medical tourism, and facilities management. During these crucial times, which may last for months or years, the HCT community must reorganize to proceed with transplantation activity in those patients who urgently require it, albeit with extreme caution. This shared knowledge may be of value to the HCT community in the absence of high-quality evidence-based medicine. © 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.

Identifiants

pubmed: 32717432
pii: S1083-8791(20)30454-7
doi: 10.1016/j.bbmt.2020.07.021
pmc: PMC7380217
pii:
doi:

Types de publication

Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

2181-2189

Informations de copyright

Copyright © 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Références

Ann Oncol. 2020 Jul;31(7):894-901
pubmed: 32224151
Emerg Infect Dis. 2020 Jul;26(7):1631-1633
pubmed: 32243255
Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):4040-4047
pubmed: 32329881
Clin Chem Lab Med. 2020 Jun 25;58(7):1131-1134
pubmed: 32119647
Eur Radiol. 2020 Oct;30(10):5720-5727
pubmed: 32415585
Lancet. 2020 May 16;395(10236):1569-1578
pubmed: 32423584
Bone Marrow Transplant. 2020 Nov;55(11):2071-2076
pubmed: 32404975
J Med Virol. 2020 Jul;92(7):791-796
pubmed: 32181911
Osteoporos Int. 2017 Mar;28(3):1027-1034
pubmed: 27844132
Aging Dis. 2020 Mar 9;11(2):216-228
pubmed: 32257537
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776
pubmed: 32054787
Am J Transplant. 2020 Jul;20(7):1879-1881
pubmed: 32243697
Lancet. 2020 May 22;:
pubmed: 32450107
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975
pubmed: 32350134
Lancet Oncol. 2020 Apr;21(4):e180
pubmed: 32142622
N Engl J Med. 2013 May 9;368(19):1771-80
pubmed: 23656642
J Clin Med. 2019 Jun 03;8(6):
pubmed: 31163625
BMJ. 2020 May 14;369:m1849
pubmed: 32409561
N Engl J Med. 2020 May 7;382(19):1787-1799
pubmed: 32187464
Biol Blood Marrow Transplant. 2015 Nov;21(11):1863-1869
pubmed: 26256941
Sci Transl Med. 2017 Jun 28;9(396):
pubmed: 28659436
JAMA. 2020 Apr 28;323(16):1582-1589
pubmed: 32219428
Clin Infect Dis. 2021 Jan 27;72(2):340-350
pubmed: 33501974
Transbound Emerg Dis. 2021 Mar;68(2):253-257
pubmed: 32536002
Front Med (Lausanne). 2020 Oct 28;7:583897
pubmed: 33195334
JAMA. 2020 Jun 23;323(24):2493-2502
pubmed: 32392282
Med. 2020 Dec 18;1(1):114-127.e3
pubmed: 32838355
Lancet Infect Dis. 2020 Oct;20(10):1118
pubmed: 32311322
Bone Marrow Transplant. 2016 Jun;51(6):778-85
pubmed: 26901703
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Autoimmun Rev. 2020 Jun;19(6):102537
pubmed: 32251717
J Clin Oncol. 2020 May 1;38(13):1463-1473
pubmed: 32083994
N Engl J Med. 2020 Jun 18;382(25):2411-2418
pubmed: 32379955
Biol Blood Marrow Transplant. 2020 Jun;26(6):1043-1049
pubmed: 32305359
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
J Crit Care. 2020 Jun;57:279-283
pubmed: 32173110
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Bone Marrow Transplant. 2020 Oct;55(10):1900-1905
pubmed: 32313181
Biol Blood Marrow Transplant. 2020 Jul;26(7):1239-1246
pubmed: 32298807
Int J Antimicrob Agents. 2020 Jul;56(1):105949
pubmed: 32205204
Am J Hematol. 2020 Aug;95(8):E210-E213
pubmed: 32419212

Auteurs

Ghada Algwaiz (G)

Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia.

Mahmoud Aljurf (M)

Department of Adult Hematology and Stem Cell Transplant, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia. Electronic address: maljurf@kfshrc.edu.sa.

Mickey Koh (M)

Department of Haematology. St George's Hospital and Medical School, London, United Kingdom; Cell Therapy Facility, Blood Services Group, Health Sciences Authority, Singapore.

Mary M Horowitz (MM)

Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Per Ljungman (P)

Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden; Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

Daniel Weisdorf (D)

Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.

Wael Saber (W)

Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Yoshihisa Kodera (Y)

Center for Hematopoietic Stem Cell Transplantation, Aichi Medical University Hospital, Nagakute, Japan.

Jeff Szer (J)

Clinical Haematology at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Dunia Jawdat (D)

Cord Blood Bank, King Abdullah International Medical Research Center, College of Science and Health Professions, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia.

William A Wood (WA)

Division of Hematology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Ruta Brazauskas (R)

Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin.

Leslie Lehmann (L)

Department of Pediatric Hematology-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Marcelo C Pasquini (MC)

Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Adriana Seber (A)

Department of Medicine, Universidade Federal de Sao Paulo Escola Paulista de Medicina: Sao Paulo, Brazil.

Pei Hua Lu (PH)

Hematology and Oncology Department, Hebei Yanda Ludaopei Hospital, Langfang, China.

Yoshiko Atsuta (Y)

Center for Hematopoietic Stem Cell Transplantation, Aichi Medical University Hospital, Nagakute, Japan.

Marcie Riches (M)

Division of Hematology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Miguel-Angel Perales (MA)

Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.

Nina Worel (N)

Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.

Shinichiro Okamoto (S)

Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

Alok Srivastava (A)

Department of Haematology, Christian Medical College, Vellore, Tamil Nadu, India.

Roy F Chemaly (RF)

Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Catherine Cordonnier (C)

Hematology Department, Henri Mondor Hospital and University Paris-Est Créteil, Créteil, France.

Christopher E Dandoy (CE)

Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio.

John R Wingard (JR)

Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, Florida.

Mohamed A Kharfan-Dabaja (MA)

Division of Hematology-Oncology, Mayo Clinic, Jacksonville, Florida.

Mehdi Hamadani (M)

Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Navneet S Majhail (NS)

Blood and Marrow Transplant Program, Cleveland Clinic, Cleveland, Ohio.

Alpana A Waghmare (AA)

Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Washington and Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

Nelson Chao (N)

Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina.

Nicolaus Kröger (N)

Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

Bronwen Shaw (B)

Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Mohamad Mohty (M)

Service d'Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, Sorbonne Université, INSERM UMRS 938, Paris, France.

Dietger Niederwieser (D)

Division of Hematology and Medical Oncology, University of Leipzig, Leipzig, Germany.

Hildegard Greinix (H)

Division of Hematology, Medical University of Graz, Graz, Austria.

Shahrukh K Hashmi (SK)

Department of Adult Hematology and Stem Cell Transplant, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH